A Phase I Study of ICP-022 in Healthy Subjects

Clinical trial NCT03189017 · COMPLETED

Trial details

NCT number: NCT03189017
Sponsor: Innocare Pharma Australia Pty Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Rheumatoid Arthritis

Start date: 2017-07-03
Primary completion: 2018-02-05
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.